Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$15.2 million.

  • Maravai Lifesciences Holdings' Cash from Operations fell 21533.19% to -$15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.4 million, marking a year-over-year decrease of 26539.99%. This contributed to the annual value of $7.5 million for FY2024, which is 9408.59% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Cash from Operations of -$15.2 million as of Q3 2025, which was down 21533.19% from -$10.3 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Cash from Operations registered a high of $165.9 million during Q2 2021, and its lowest value of -$15.2 million during Q3 2025.
  • For the 5-year period, Maravai Lifesciences Holdings' Cash from Operations averaged around $52.8 million, with its median value being $19.2 million (2023).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Cash from Operations soared by 132866.12% in 2021, and later crashed by 28790.76% in 2024.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Cash from Operations stood at $58.7 million in 2021, then soared by 69.1% to $99.3 million in 2022, then plummeted by 92.16% to $7.8 million in 2023, then crashed by 287.91% to -$14.6 million in 2024, then dropped by 3.5% to -$15.2 million in 2025.
  • Its Cash from Operations was -$15.2 million in Q3 2025, compared to -$10.3 million in Q2 2025 and -$9.4 million in Q1 2025.